Personal information

Other IDs

Scopus Author ID: 6506663985

Keywords

radition Oncology

Countries

Spain

Activities

Collapse all

Employment (2)

Consorcio Hospitalario Provincial de Castellón: Castelló de la Plana, Comunidad Valenciana, ES

2006-03-15 to present | Oncology Institute Director (Oncology)
Employment
Source: Self-asserted source
Carlos Ferrer Albiach

Universidad CEU Cardenal Herrera: Castellon, Comunitat Valenciana, ES

2013-09-15 to 2021-06-01 | Associate Professor Oncology (Medicina )
Employment
Source: Self-asserted source
Carlos Ferrer Albiach

Education and qualifications (1)

Facultad de medicina : Valencia, Valencia Comunidad Valenciana, ES

1995 to present | doctoral degree (Medicina)
Education
Source: Self-asserted source
Carlos Ferrer Albiach

Professional activities (4)

Royal Academy of Medicine : Valencia, Valencian Community, ES

2013-05 to present | Academic
Service
Source: Self-asserted source
Carlos Ferrer Albiach

Sociedad Española de Oncologia Radioterápica: Madrid, Comunidad de madrid, ES

2017-06-15 to 2019-06-15 | President
Service
Source: Self-asserted source
Carlos Ferrer Albiach

International Atomic Energy Agency: Vienna, AT

2018-11 to 2018-11 | expert (Radiotherapy)
Distinction
Source: Self-asserted source
Carlos Ferrer Albiach

Hospital Provincial Castellón: Castellon de la Plana, Valenciana, ES

2013-02-15 to 2016-06-15 | Scientific Director
Service
Source: Self-asserted source
Carlos Ferrer Albiach

Funding (9)

Registro prospectivo de hipofraccionamiento con fotonterapia y protonterapia con sobreimpresión en zona con Ga-PSMA positiva en el rescate tras prostatectomía

2021-01 to 2023-12 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI20/01598
Source: Self-asserted source
Carlos Ferrer Albiach

Alteraciones de MYC en cancer de prostata localizado y avanzado implicaciones clinicas y moleculares

2020-10 to 2023-12 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI20/01642
Source: Self-asserted source
Carlos Ferrer Albiach

Image-guided simulation and treatment in ratiotherapy -

2010 to 2013 | Grant
Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

IPT-300000-2010-3
Source: Self-asserted source
Carlos Ferrer Albiach

Subprograma INNPACTO: Simulación y tratamiento guiado por imagen en radioterapia (PRECISION)

2010 to 2013 | Grant
Ministerio de Ciencia e Innovación (Madrid, Madrid, ES)
GRANT_NUMBER:

IPT300000-2010-3.

Source: Self-asserted source
Carlos Ferrer Albiach

Multihospital study on simulation and training in clinical practice optimization in intraoperative radiotherapy -

2010 to 2011 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI09/90628

Source: Self-asserted source
Carlos Ferrer Albiach

Investigaciones en tecnologías de tratamiento guiado por imagen y simulación para una práctica clínica segura. S2. Algoritmos dosimetría

2009 to 2010 | Grant
Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

PSE-300000-2009-5//PSS-300000-2009-25
Source: Self-asserted source
Carlos Ferrer Albiach

Viability and clinical usefulness evaluation of a planning and simulation system for intraoperative radiotherapy

2009 to 2010 | Grant
Ministerio de Ciencia y Tecnología (Madrid, ES)
GRANT_NUMBER:

FISS-ETES 2008 (PI 08-90473)
Source: Self-asserted source
Carlos Ferrer Albiach

Técnicas de análisis de imagen aplicadas al control de calidad en radioterapia

2003-12 to 2006-11 | Grant
Ministerio de Ciencia y Tecnología (Castellon, Comunidad Valenciana, ES)
GRANT_NUMBER:

TIC2003-06953
Source: Self-asserted source
Carlos Ferrer Albiach

Sistema de teleguiado, planificación y automatización pre-robotizada de tratamientos de Radioterapia IntraOperatoria II

Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

PI11/01659
Source: Self-asserted source
Carlos Ferrer Albiach
grade
Preferred source (of 2)‎

Works (50 of 70)

Items per page:
Page 1 of 2

MARRTA: Risk matrix in advanced radiotherapy.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
2024-10 | Journal article
DOI: 10.1016/j.ejmp.2024.104846
PMID: 39471664
Contributors: Rot San Juan MJ; Delgado Rodríguez JM; Prieto Martín C; Pérez-Mulas A; Sánchez Cayuela C; Vilanova Ciscar J; Ramírez Vera ML; Ferreras Hernández E; Suárez Hernández MJ
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction.

Cancers
2023-08 | Journal article
DOI: 10.3390/cancers15164163
PMID: 37627191
PMC: PMC10453281
Contributors: Sánchez Iglesias Á; Morillo Macías V; Picó Peris A; Fuster-Matanzo A; Nogué Infante A; Muelas Soria R; Bellvís Bataller F; Domingo Pomar M; Ferrer Albiach C
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Intra-Operative Electron Radiation Therapy: An Update of the Evidence Collected in 40 Years to Search for Models for Electron-FLASH Studies

Cancers
2022 | Journal article
Source: Self-asserted source
Carlos Ferrer Albiach

Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience.

Radiation oncology journal
2022-09 | Journal article
DOI: 10.3857/roj.2022.00101
PMID: 36200308
PMC: PMC9535412
Contributors: Sánchez-Iglesias ÁL; Morillo-Macías V; Santafé-Jiménez A; Ferrer-Albiach C
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Intra-Operative Electron Radiation Therapy: An Update of the Evidence Collected in 40 Years to Search for Models for Electron-FLASH Studies

Cancers
2022-07-29 | Journal article
DOI: 10.3390/cancers14153693
Contributors: Felipe A. Calvo; Javier Serrano; Mauricio Cambeiro; Javier Aristu; Jose Manuel Asencio; Isabel Rubio; Jose Miguel Delgado; Carlos Ferrer; Manuel Desco; Javier Pascau
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The Usefulness of Adaptative Radiotherapy in Prostate Cancer: How, When, and Who?

Biomedicines
2022-06-13 | Journal article
DOI: 10.3390/biomedicines10061401
Contributors: Rodrigo Muelas-Soria; Rafael García-Mollá; Virginia Morillo-Macías; Jorge Bonaque-Alandí; Patricia Sorribes-Carreras; Francisco García-Piñón; Carlos Ferrer-Albiach
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The Impact of Frailty Screening on Radiation Treatment Modification

Cancers
2022-02 | Journal article | Author
DOI: 10.3390/cancers14041072
Contributors: Encarnación Fernández Camacho; Carlos Ferrer-Ramos; Virginia Morillo Macías; Marta Rodríguez-Cordón; Angel L. Sanchez-Iglesias; Inmaculada Beato-Tortajada; Alicia Francés-Muñoz; Rodrigo Muelas-Soria; Teresa Piquer-Camañes; Ana Santafe Jimenez et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Nomogram for the personalisation of radiotherapy treatments in breast cancer patients.

Breast (Edinburgh, Scotland)
2021-11 | Journal article
DOI: 10.1016/j.breast.2021.11.004
PMID: 34808437
PMC: PMC8609093
Contributors: Beato Tortajada I; Ferrer Albiach C; Morillo Macias V
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer.

International journal of radiation oncology, biology, physics
2021-11 | Journal article
DOI: 10.1016/j.ijrobp.2021.07.151
PMID: 34700589
Contributors: Conde-Moreno AJ; Lopez F; Hervas A; Morillo V; Mendez A; Puertas MDM; Albarrán JV; De Iturriaga AG; Rico M; Vázquez de la Torre ML et al.
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas

Clinical and Translational Oncology
2021-10 | Journal article
DOI: 10.1007/s12094-021-02622-9
Contributors: R. Garcia-Carbonero; F. Matute Teresa; E. Mercader-Cidoncha; M. Mitjavila-Casanovas; M. Robledo; I. Tena; C. Alvarez-Escola; M. Arístegui; M. R. Bella-Cueto; C. Ferrer-Albiach et al.
Source: check_circle
Crossref

Early PSA Decline In Metastatic Prostate Cancer Treated With Abiraterone

International Journal of Radiation Oncology*Biology*Physics
2020-11 | Journal article
DOI: 10.1016/j.ijrobp.2020.07.561
Part of ISSN: 0360-3016
Source: Self-asserted source
Carlos Ferrer Albiach

In response to Haas RL et al.

Radiotherapy and Oncology
2020-10 | Journal article
DOI: 10.1016/j.radonc.2020.10.014
Part of ISSN: 0167-8140
Source: Self-asserted source
Carlos Ferrer Albiach

Intraoperative radiation therapy (IORT) for soft tissue sarcoma – ESTRO IORT Task Force/ACROP recommendations

Radiotherapy and Oncology
2020-09 | Journal article
DOI: 10.1016/j.radonc.2020.07.019
Part of ISSN: 0167-8140
Source: Self-asserted source
Carlos Ferrer Albiach

SEOR recommendations on the use of protons

Clinical and Translational Oncology
2020-06-12 | Journal article
DOI: 10.1007/s12094-019-02194-9
Contributors: M. Lloret-Saez-Bravo; J. Giralt-L de Sagredo; J. Contreras-Martinez; C. Ferrer-Albiach
Source: check_circle
Crossref

Patient safety in radiation oncology in Spain: a need to change

Clinical and Translational Oncology
2020-05 | Journal article
DOI: 10.1007/s12094-019-02184-x
Part of ISSN: 1699-048X
Part of ISSN: 1699-3055
Source: Self-asserted source
Carlos Ferrer Albiach

Safety in radiation oncology: transposition of directive 2013/59/EURATOM in the Spanish Radiation Oncology Departments-recommendations for its adequate and effective application.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2020-05-22 | Journal article
DOI: 10.1007/s12094-020-02359-x
PMID: 32445036
Source: Self-asserted source
Carlos Ferrer Albiach

Time for radioimmunotherapy: an overview to bring improvements in clinical practice

Clinical and Translational Oncology
2019 | Journal article
DOI: 10.1007/s12094-018-02027-1
EID:

2-s2.0-85060133797
Contributors: Leaman Alcibar, O.; Candini, D.; López-Campos, F.; Albert Antequera, M.; Morillo Macías, V.; Conde, A.J.; Rodríguez Pérez, A.; Hervás Morón, A.; Contreras Martínez, J.; Ferrer Albiach, C. et al.
Source: Self-asserted source
Carlos Ferrer Albiach via Scopus - Elsevier

Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter study.

BMC cancer
2019-11 | Journal article
DOI: 10.1186/s12885-019-6390-x
PMID: 31783816
PMC: PMC6884857
Contributors: Rades D; Hansen O; Jensen LH; Dziggel L; Staackmann C; Doemer C; Cacicedo J; Conde-Moreno AJ; Segedin B; Ciervide-Jurio R et al.
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Patient-Reported Outcomes-Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy × 5 to 3 Gy × 10 for Metastatic Epidural Spinal Cord Compression.

International journal of radiation oncology, biology, physics
2019-08 | Journal article
DOI: 10.1016/j.ijrobp.2019.08.002
PMID: 31415797
Contributors: Rades D; Šegedin B; Conde-Moreno AJ; Ferrer-Albiach C; Metz M; Polat B; Badakhshi H; Schreiber A; Nitsche M; Cacicedo J et al.
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain.

Journal of pain research
2019-07 | Journal article
DOI: 10.2147/jpr.s194881
PMID: 31372030
PMC: PMC6636433
Contributors: Ferrer Albiach C; Villegas Estévez F; López Alarcón MD; de Madariaga M; Carregal A; Arranz J; Trinidad Martín-Arroyo JM; Jiménez López AJ; Sanz Yagüe A
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

MicroRNA95 May Be Involved in Oligometastatic Prostate Cancer

Journal of Cancer Treatment and Research
2019-01-19 | Journal article
DOI: 10.11648/j.jctr.20190702.12
Source: Self-asserted source
Carlos Ferrer Albiach

Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology

Clinical and Translational Oncology
2018 | Journal article
DOI: 10.1007/s12094-018-1940-2
EID:

2-s2.0-85054711178
Contributors: Gómez-Caamaño, A.; González-San Segundo, C.; Henríquez, I.; Maldonado, X.; Zapatero, A.; Cabeza Rodríguez, M.A.; Celada Álvarez, F.; Ferrer Albiach, C.; Ferrer González, F.; Gómez-Iturriaga, A. et al.
Source: Self-asserted source
Carlos Ferrer Albiach via Scopus - Elsevier

Quality indicators in radiation oncology: proposal of the Spanish Society of Radiation Oncology (SEOR) for a continuous improvement of the quality of care in oncology.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2018-10 | Journal article
DOI: 10.1007/s12094-018-1943-z
PMID: 30311145
Contributors: López Torrecilla J; Marín I Borràs S; Ruiz-Alonso A; Jaen Olasolo J; Vázquez de la Torre ML; Bóveda Carro E; Rodríguez A; Ignacio García E; Ferrer Albiach C
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central
grade
Preferred source (of 2)‎

New wind for the Spanish Federation of Scientific Oncological Societies (FESEO).

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2018-07 | Journal article
DOI: 10.1007/s12094-018-1898-0
PMID: 29876758
Contributors: González-Moreno S; FESEO Board of Directors
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015–2020

Clinical and Translational Oncology
2018-03 | Journal article
DOI: 10.1007/s12094-017-1727-x
Part of ISSN: 1699-048X
Part of ISSN: 1699-3055
Source: Self-asserted source
Carlos Ferrer Albiach

Rescuing Spanish Radiation Therapy: The Role of Leadership and Opportunity.

International journal of radiation oncology, biology, physics
2018-02 | Journal article
DOI: 10.1016/j.ijrobp.2017.09.006
PMID: 29353648
Contributors: Lara PC; Rodríguez A; Ferrer C; Aristu JJ; Prada PJ; Muñoz J; Arenas M; Perez-Montero H
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.

The New England journal of medicine
2018-02-08 | Journal article
DOI: 10.1056/nejmoa1715546
PMID: 29420164
Source: Self-asserted source
Carlos Ferrer Albiach
grade
Preferred source (of 2)‎

Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer

Clinical and Translational Oncology
2017 | Journal article
DOI: 10.1007/s12094-016-1563-4
EID:

2-s2.0-84992735169
Contributors: Conde-Moreno, A.J.; Herrando-Parreño, G.; Muelas-Soria, R.; Ferrer-Rebolleda, J.; Broseta-Torres, R.; Cozar-Santiago, M.P.; García-Piñón, F.; Ferrer-Albiach, C.
Source: Self-asserted source
Carlos Ferrer Albiach via Scopus - Elsevier

Erratum to: Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2017-09 | Journal article
DOI: 10.1007/s12094-017-1636-z
PMID: 28299579
PMC: PMC5547180
Contributors: Vera R; Ferrández A; Ferrer CJ; Flores C; Joaquín C; López S; Martín T; Martín E; Marzo M; Sarrión A et al.
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study

Clinical and Translational Oncology
2017-03 | Journal article
DOI: 10.1007/s12094-016-1538-5
Part of ISSN: 1699-048X
Part of ISSN: 1699-3055
Source: Self-asserted source
Carlos Ferrer Albiach

Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
2017-01 | Journal article
DOI: 10.1007/s12094-016-1609-7
PMID: 28105537
PMC: PMC5486521
Contributors: Vera R; Ferrández A; Ferrer CJ; Flores C; Joaquín C; López S; Martín T; Martín E; Marzo M; Sarrión A et al.
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

What can statistical process control show us about ionization chamber stability?

Radiation Measurements
2016 | Journal article
DOI: 10.1016/j.radmeas.2015.12.041
EID:

2-s2.0-84954104317
Contributors: López-Tarjuelo, J.; Quirós-Higueras, J.D.; Bonaque-Alandí, J.; Luquero-Llopis, N.; García-Mollá, R.; Juan-Senabre, X.J.; De Marco-Blancas, N.; Ferrer-Albiach, C.; Santos-Serra, A.
Source: Self-asserted source
Carlos Ferrer Albiach via Scopus - Elsevier

Practical issues regarding angular and energy response in in vivo intraoperative electron radiotherapy dosimetry.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
2016-10 | Journal article
DOI: 10.1016/j.rpor.2016.09.009
PMID: 27790075
PMC: PMC5072178
Contributors: López-Tarjuelo J; Bouché-Babiloni A; Morillo-Macías V; Santos-Serra A; Ferrer-Albiach C
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central
grade
Preferred source (of 2)‎

Implementation of an intraoperative electron radiotherapy in vivo dosimetry program.

Radiation oncology (London, England)
2016-03 | Journal article
DOI: 10.1186/s13014-016-0621-y
PMID: 26980076
PMC: PMC4793509
Contributors: López-Tarjuelo J; Morillo-Macías V; Bouché-Babiloni A; Boldó-Roda E; Lozoya-Albacar R; Ferrer-Albiach C
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central
grade
Preferred source (of 2)‎

Laterally Extended Endopelvic Resection (Leer) and Reconstructive Techniques for Treatment of Locally Advanced Cervix Cancer: A Case Report

International Journal of Gynecology & Clinical Practices
2016-01-01 | Journal article
DOI: 10.15344/2394-4986/2016/120
Source: Self-asserted source
Carlos Ferrer Albiach

Erratum: Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options.

Radiation oncology (London, England)
2015-07 | Journal article
DOI: 10.1186/s13014-015-0444-2
PMID: 26216408
PMC: PMC4517639
Contributors: Moreno AJ; Albiach CF; Soria RM; Vidal VG; Gómez RG; Antequera MA
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Defining Action Levels for In Vivo Dosimetry in Intraoperative Electron Radiotherapy.

Technology in cancer research & treatment
2015-05 | Journal article
DOI: 10.1177/1533034615588196
PMID: 26025385
Contributors: López-Tarjuelo J; Morillo-Macías V; Bouché-Babiloni A; Ferrer-Albiach C; Santos-Serra A
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central
grade
Preferred source (of 2)‎

Statistical process control for electron beam monitoring.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
2015-05 | Journal article
DOI: 10.1016/j.ejmp.2015.05.006
PMID: 26032002
Contributors: López-Tarjuelo J; Luquero-Llopis N; García-Mollá R; Quirós-Higueras JD; Bouché-Babiloni A; Juan-Senabre XJ; de Marco-Blancas N; Ferrer-Albiach C; Santos-Serra A
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central
grade
Preferred source (of 2)‎

Fractionated stereotactic radiotherapy plus bevacizumab after response to bevacizumab plus irinotecan as a rescue treatment for high-grade gliomas.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
2015-02 | Journal article
DOI: 10.1016/j.rpor.2015.01.004
PMID: 25949228
PMC: PMC4418580
Contributors: Conde-Moreno AJ; García-Gómez R; Albert-Antequera M; Almendros-Blanco P; De Las Peñas-Bataller R; González-Vidal V; López-Torrecilla JL; Ferrer-Albiach C
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central
grade
Preferred source (of 2)‎

Intraoperative radiotherapy for gastrointestinal malignancies: contemporary outcomes with multimodality therapy.

Current oncology reports
2015-01 | Journal article
DOI: 10.1007/s11912-014-0419-8
PMID: 25416313
Contributors: Calvo FA; Sole CV; Marsiglia H; Alvarado E; Ferrer C; Czito B
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options.

Radiation oncology (London, England)
2014-12 | Journal article
DOI: 10.1186/s13014-014-0258-7
PMID: 25497220
PMC: PMC4272793
Contributors: Conde Moreno AJ; Ferrer Albiach C; Muelas Soria R; González Vidal V; García Gómez R; Albert Antequera M
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Failure mode and effect analysis oriented to risk-reduction interventions in intraoperative electron radiation therapy: the specific impact of patient transportation, automation, and treatment planning availability.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
2014-11 | Journal article
DOI: 10.1016/j.radonc.2014.11.012
PMID: 25465728
Contributors: López-Tarjuelo J; Bouché-Babiloni A; Santos-Serra A; Morillo-Macías V; Calvo FA; Kubyshin Y; Ferrer-Albiach C
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central
grade
Preferred source (of 2)‎

Human cytomegalovirus and Epstein-Barr virus infection impact on (18)F-FDG PET/CT SUVmax, CT volumetric and KRAS-based parameters of patients with locally advanced rectal cancer treated with neoadjuvant therapy.

European journal of nuclear medicine and molecular imaging
2014-10 | Journal article
DOI: 10.1007/s00259-014-2910-8
PMID: 25269837
Contributors: Sole CV; Calvo FA; Ferrer C; Alvarez E; Carreras JL; Ochoa E
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Bibliometrics of intraoperative radiotherapy: analysis of technology, practice and publication tendencies.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
2014-06 | Journal article
DOI: 10.1007/s00066-014-0695-0
PMID: 24928250
Contributors: Sole CV; Calvo FA; Ferrer C; Pascau J; Marsiglia H
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

In vivo dosimetry in intraoperative electron radiotherapy: microMOSFETs, radiochromic films and a general-purpose linac.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
2014-06 | Journal article
DOI: 10.1007/s00066-014-0689-y
PMID: 24965479
Contributors: López-Tarjuelo J; Bouché-Babiloni A; Morillo-Macías V; de Marco-Blancas N; Santos-Serra A; Quirós-Higueras JD; Ferrer-Albiach C
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central
grade
Preferred source (of 2)‎

Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomes.

Journal of cancer research and clinical oncology
2014-06 | Journal article
DOI: 10.1007/s00432-014-1718-z
PMID: 24880919
Contributors: Calvo FA; Morillo V; Santos M; Serrano J; Gomez-Espí M; Rodriguez M; Del Vale E; Gracia-Sabrido JL; Ferrer C; Sole C
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Adjusting the dose of tamoxifen in patients with early breast cancer and CYP2D6 poor metabolizer phenotype.

Breast (Edinburgh, Scotland)
2014-03 | Journal article
DOI: 10.1016/j.breast.2014.02.008
PMID: 24685597
Contributors: Martinez de Dueñas E; Ochoa Aranda E; Blancas Lopez-Barajas I; Ferrer Magdalena T; Bandrés Moya F; Chicharro García LM; Gómez Capilla JA; Olmos Antón S
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central
grade
Preferred source (of 2)‎

Research opportunities in intraoperative radiation therapy: the next decade 2013–2023

Clinical and Translational Oncology
2013-09 | Journal article
DOI: 10.1007/s12094-013-1019-z
Part of ISSN: 1699-048X
Part of ISSN: 1699-3055
Source: Self-asserted source
Carlos Ferrer Albiach

Clinical significance of VEGFR-2 and ¹⁸F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy.

European journal of nuclear medicine and molecular imaging
2013-06 | Journal article
DOI: 10.1007/s00259-013-2479-7
PMID: 23801169
Contributors: Sole CV; Calvo FA; Alvarez E; Peligros I; Garcia-Alfonso P; Ferrer C; Ochoa E; Herranz R; Carreras JL
Source: Self-asserted source
Carlos Ferrer Albiach via Europe PubMed Central

Intraoperative radiotherapy with electrons: fundamentals, results, and innovation

Ecancermedicalscience
2013-01-01 | Journal article
DOI: 10.3332/ecancer.2013.339
Source: Self-asserted source
Carlos Ferrer Albiach
Items per page:
Page 1 of 2

Peer review (7 reviews for 1 publication/grant)

Review activity for Clinical & translational oncology. (7)
How many people are using ORCID?